Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'TUMOR-IMMUNITY' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 271 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Pittet, MJ; Speiser, DE; Valmori, D; Rimoldi, D; Lienard, D; Lejeune, F; Cerottini, JC; Romero, P
      Ex vivo analysis of tumor antigen specific CD8(+) T cell responses using MHC/peptide tetramers in cancer patients

      INTERNATIONAL IMMUNOPHARMACOLOGY
    2. Dan, QH; Sanchez, R; Delgado, C; Wepsic, HT; Morgan, K; Chen, YJ; Jeffes, EWB; Lowell, CA; Morgan, TR; Jadus, MR
      Non-immunogenic murine hepatocellular carcinoma Hepa1-6 cells expressing the membrane form of macrophage colony stimulating factor are rejected in vivo and lead to CD8+ T-Cell immunity against the parental tumor

      MOLECULAR THERAPY
    3. Nakano, K; Todo, T; Chijiiwa, K; Tanaka, M
      Therapeutic efficacy of G207, a conditionally replicating herpes simplex virus type 1 mutant, for gallbladder carcinoma in immunocompetent hamsters

      MOLECULAR THERAPY
    4. Williams, CC; Trinh, H; Tran, TV; Dan, QH; Sanchez, R; Delgado, C; Chen, YJ; Sippel, B; Jeffes, EWB; Wepsic, HT; Jadus, MR
      Membrane macrophage colony-stimulating factor on MADB106 breast cancer cells does not activate cytotoxic macrophages but immunizes rats against breast cancer

      MOLECULAR THERAPY
    5. Harada, M; Li, YF; El-Gamil, M; Ohnmacht, GA; Rosenberg, SA; Robbins, PF
      Melanoma-reactive CD8(+) T cells recognize a novel tumor antigen expressedin a wide variety of tumor types

      JOURNAL OF IMMUNOTHERAPY
    6. Sun, H; Kundu, N; Dorsey, R; Jackson, MJ; Fulton, AM
      Expression of the chemokines IP-10 and Mig in IL-10 transduced tumors

      JOURNAL OF IMMUNOTHERAPY
    7. Weiskirch, LM; Pan, ZK; Paterson, Y
      The tumor recall response of antitumor immunity primed by a live, recombinant Listeria monocytogenes vaccine comprises multiple effector mechanisms

      CLINICAL IMMUNOLOGY
    8. Dobrzanski, MJ; Reome, JB; Dutton, RW
      Immunopotentiating role of IFN-gamma in early and late stages of type 1 CD8 effector cell-mediated tumor rejection

      CLINICAL IMMUNOLOGY
    9. Tanaka, Y; Koido, S; Chen, DS; Gendler, SJ; Kufe, D; Gong, JL
      Vaccination with allogeneic dendritic induces antitumor immunity in cells fused to carcinoma cells MUC1 transgenic mice

      CLINICAL IMMUNOLOGY
    10. Berwin, B; Nicchitta, CV
      To find the road traveled to tumor immunity: The trafficking itineraries of molecular chaperones in antigen-presenting cells

      TRAFFIC
    11. Sakaguchi, S; Takahashi, T; Yamazaki, S; Kuniyasu, Y; Itoh, M; Sakaguchi, N; Shimizu, J
      Immunologic self tolerance maintained by T-cell-mediated control of self-reactive T cells: Implications for autoimmunity and tumor immunity

      MICROBES AND INFECTION
    12. Sicard, H; Al Saati, T; Delsol, G; Fournie, JJ
      Synthetic phosphoantigens enhance human V gamma 9V delta 2 T lymphocytes killing of non-Hodgkin's B lymphoma

      MOLECULAR MEDICINE
    13. Rad, AN; Schlom, J; Hodge, JW
      Vector-driven hyperexpression of a triad of costimulatory molecules confers enhanced T-cell stimulatory capacity to DC precursors

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    14. Gunzer, M; Grabbe, S
      Dendritic cells in cancer immunotherapy

      CRITICAL REVIEWS IN IMMUNOLOGY
    15. Vonderheide, RH; Butler, MO; Liu, JF; Battle, TE; Hirano, N; Gribben, JG; Frank, DA; Schultze, JL; Nadler, LM
      CD40 activation of carcinoma cells increases expression of adhesion and major histocompatibility molecules but fails to induce either CD80/CD86 expression or T cell alloreactivity

      INTERNATIONAL JOURNAL OF ONCOLOGY
    16. Akagi, J; Takai, E; Tamori, Y; Ogawa, M
      CD3(+)CD56(+)CD8(+) cells demonstrating a suppressor T cell-like function in the peripheral blood of colon cancer patients

      INTERNATIONAL JOURNAL OF ONCOLOGY
    17. Thomas, R; Padmanabha, J; Chambers, M; McFadyen, S; Walpole, E; Nielssen, G; Smithers, M
      Metastatic lesions in the joint associated with acute inflammatory arthritis after dendritic cell immunotherapy for metastatic melanoma

      MELANOMA RESEARCH
    18. Halliday, GM; Le, S
      Transforming growth factor-beta produced by progressor tumors inhibits, while IL-10 produced by regressor tumors enhances, Langerhans cell migration from skin

      INTERNATIONAL IMMUNOLOGY
    19. Markiewicz, MA; Fallarino, F; Ashikari, A; Gajewski, TF
      Epitope spreading upon P815 tumor rejection triggered by vaccination with the single class I MHC-restricted peptide P1A

      INTERNATIONAL IMMUNOLOGY
    20. Smyth, MJ; Crowe, NY; Godfrey, DI
      NK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma

      INTERNATIONAL IMMUNOLOGY
    21. Morikane, K; Tempero, RM; Sivinski, CL; Kitajima, S; Gendler, SJ; Hollingsworth, MA
      Influence of organ site and tumor cell type on MUC1-specific tumor immunity

      INTERNATIONAL IMMUNOLOGY
    22. Yano, T; Ishikura, H; Kato, H; Ogawa, Y; Kondo, S; Kato, H; Yoshiki, T
      Vaccination effect of interleukin-6-producing pancreatic cancer cells in nude mice: A model of tumor prevention and treatment in immune-compromised patients

      JAPANESE JOURNAL OF CANCER RESEARCH
    23. Matsushita, R; Hattori, K; Hayashi, K; Iizasa, H; Ichimura, F; Nakashima, E
      Synergistic effect of indomethacin and bleomycin on tumor growth produced by activating antitumor immunity

      PHARMACEUTICAL RESEARCH
    24. Takayanagi, T; Ohuchi, A
      A mathematical analysis of the interactions between immunogenic tumor cells and cytotoxic T lymphocytes

      MICROBIOLOGY AND IMMUNOLOGY
    25. Tao, GS; Hu, JY; Zou, HW; Lin, QH; Liu, FY; Wu, YL; Sun, QB
      Therapeutic antitumor response to cervical cancer in mice immunized with U14 vaccines transfected with costimulatory B7 gene

      CHINESE MEDICAL JOURNAL
    26. Dietz, AB; Litzow, MR; Gastineau, DA; Vuk-Pavlovic, S
      Engineering dendritic cell grafts for clinical trials in cellular immunotherapy of cancer: Example of chronic myelogenous leukemia

      CROATIAN MEDICAL JOURNAL
    27. Stater, LM; Stupecky, M; Sweet, P; Osann, K; Eklof, A; Arquilla, ER
      Etoposide induction of tumor immunity in Lewis lung cancer

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    28. Bergmann-Leitner, ES; Abrams, SI
      Treatment of human colon carcinoma cell lines with anti-neoplastic agents enhances their lytic sensitivity to antigen-specific CD8(+) cytotoxic T lymphocytes

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    29. Prins, RM; Graf, MR; Merchant, RE
      Cytotoxic T cells infiltrating a glioma express an aberrant phenotype thatis associated with decreased function and apoptosis

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    30. Chong, SY; Zhang, M; Lin, YC; Coffman, F; Garcia, Z; Ponzio, N; Raveche, ES
      The growth-regulatory role of B-cell-specific activator protein in NZB malignant B-1 cells

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    31. Van Pel, A; De Plaen, E; Duffour, MT; Warnier, G; Uyttenhove, C; Perricaudet, M; Boon, T
      Induction of cytolytic T lymphocytes by immunization of mice with an adenovirus containing a mouse homolog of the human MAGE-A genes

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    32. Ryan, MH; Abrams, SI
      Characterization of CD8(+) cytotoxic T lymphocyte/tumor cell interactions reflecting recognition of an endogenously expressed murine wild-type p53 determinant

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    33. Kim, KY; Kang, MA; Nam, MJ
      Enhancement of natural killer cell-mediated cytotoxicity by coexpression of GM-CSF/B70 in hepatoma

      CANCER LETTERS
    34. Burgess, SC; Basaran, BH; Davison, TF
      Resistance to Marek's disease herpesvirus-induced lymphoma is multiphasic and dependent on host genotype

      VETERINARY PATHOLOGY
    35. Siemens, DR; Ratliff, TL
      Vaccines in urologic malignancies

      UROLOGICAL RESEARCH
    36. Osborne, A; Zhang, HQ; Yang, WM; Seto, E; Blanck, G
      Histone deacetylase activity represses gamma interferon-inducible HLA-DR gene expression following the establishment of a DNase I-hypersensitive chromatin conformation

      MOLECULAR AND CELLULAR BIOLOGY
    37. Hodge, JW; Grosenbach, DW; Rad, AN; Giuliano, M; Sabzevari, H; Schlom, J
      Enhancing the potency of peptide-pulsed antigen presenting cells by vector-driven hyperexpression of a triad of costimulatory molecules

      VACCINE
    38. Ohm, JE; Carbone, DP
      VEGF as a Mediator of tumor-associated immunodeficiency

      IMMUNOLOGIC RESEARCH
    39. N'cho, M; Brahmi, Z
      Evidence that Fas-induced apoptosis leads to S phase arrest

      HUMAN IMMUNOLOGY
    40. Wataya, H; Kamikawaji, N; Nakanishi, Y; Takayama, K; Hara, N; Sasazuki, T
      Quantitation of HLA-A*0201 bound tumor associated antigens on a peptide pulsed B cell line

      HUMAN IMMUNOLOGY
    41. Schmitt, WE; Stassar, MJJG; Schmitt, W; Little, M; Cochlovius, B
      In vitro induction of a bladder cancer-specific T-cell response by mRNA-transfected dendritic cells

      JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
    42. Badie, B; Schartner, J; Prabakaran, S; Paul, J; Vorpahl, J
      Expression of Fas ligand by microglia: possible role in glioma immune evasion

      JOURNAL OF NEUROIMMUNOLOGY
    43. Musunuru, K; Darnell, RB
      Paraneoplastic neurologic disease antigens: RNA-binding proteins and signaling proteins in neuronal degeneration

      ANNUAL REVIEW OF NEUROSCIENCE
    44. Revaz, V; Benyacoub, J; Kast, WM; Schiller, JT; De Grandi, P; Nardelli-Haefliger, D
      Mucosal vaccination with a recombinant Salmonella typhimurium expressing human papillomavirus type 16 (HPV16) L1 virus-like particles (VLPs) or HPV16VLPs purified from insect cells inhibits the growth of HPV16-expressing tumor cells in mice

      VIROLOGY
    45. Hirahara, N; Nio, Y; Sasaki, S; Minari, Y; Takamura, M; Iguchi, C; Dong, M; Yamasawa, K; Tamura, K
      Inoculation of human interleukin-17 gene-transfected meth-A fibrosarcoma cells induces T cell-dependent tumor-specific immunity in mice

      ONCOLOGY
    46. Hellstrom, I; Ledbetter, JA; Scholler, N; Yang, Y; Ye, ZM; Goodman, G; Pullman, J; Hayden-Ledbetter, M; Hellstrom, KE
      CD3-mediated activation of tumor-reactive lymphocytes from patients with advanced cancer

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    47. Nozawa, K; Ohata, J; Sakurai, J; Hashimoto, H; Miyajima, H; Yagita, H; Okumura, K; Azuma, M
      Preferential blockade of CD8(+) T cell responses by administration of anti-CD137 ligand monoclonal antibody results in differential effect on development of murine acute and chronic graft-versus-host diseases

      JOURNAL OF IMMUNOLOGY
    48. Fong, L; Brockstedt, D; Benike, C; Breen, JK; Strang, G; Ruegg, CL; Engleman, EG
      Dendritic cell-based xenoantigen vaccination for prostate cancer immunotherapy

      JOURNAL OF IMMUNOLOGY
    49. Siemens, DR; Elzey, BD; Lubaroff, DM; Bohlken, C; Jensen, RJ; Swanson, AK; Ratliff, TL
      Cutting edge: Restoration of the ability to generate CTL in mice immune toadenovirus by delivery of virus in a collagen-based matrix

      JOURNAL OF IMMUNOLOGY
    50. Helmich, BK; Dutton, RW
      The role of adoptively transferred CD8 T cells and host cells in the control of the growth of the EG7 thymoma: Factors that determine the relative effectiveness and homing properties of Tc1 and Tc2 effectors

      JOURNAL OF IMMUNOLOGY
    51. Fonteneau, JF; Larsson, M; Somersan, S; Sanders, C; Munz, C; Kwok, WW; Bhardwaj, N; Jotereau, F
      Generation of high quantities of viral and tumor-specific human CD4+and CD8+T-cell clones using peptide pulsed mature dendritic cells

      JOURNAL OF IMMUNOLOGICAL METHODS
    52. Liu, XL; Bai, XF; Wen, J; Gao, JX; Liu, JQ; Lu, P; Wang, Y; Zheng, P; Liu, Y
      B7H costimulates clonal expansion of, and cognate destruction of tumor cells by, CD8(+) T lymphocytes in vivo

      JOURNAL OF EXPERIMENTAL MEDICINE
    53. Tangri, S; Ishioka, GY; Huang, XQ; Sidney, J; Southwood, S; Fikes, S; Sette, A
      Structural features of peptide analogs of human histocompatibility leukocyte antigen class I epitopes that are more potent and immunogenic than wild-type peptide

      JOURNAL OF EXPERIMENTAL MEDICINE
    54. Smyth, MJ; Cretney, E; Takeda, K; Wiltrout, RH; Sedger, LM; Kayagaki, N; Yagita, H; Okumura, K
      Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon gamma-dependent natural killer cell protection from tumor metastasis

      JOURNAL OF EXPERIMENTAL MEDICINE
    55. Andersen, MH; Keikavoussi, P; Brocker, EB; Schuler-Thurner, B; Jonassen, M; Sondergaard, I; Straten, PT; Becker, JC; Kampgen, E
      Induction of systemic CTL responses in melanoma patients by dendritic cellvaccination: Cessation of CTL responses is associated with disease progression

      INTERNATIONAL JOURNAL OF CANCER
    56. Jurianz, K; Ziegler, S; Donin, N; Reiter, Y; Fishelson, Z; Kirschfink, M
      K562 erythroleukemic cells are equipped with multiple mechanisms of resistance to lysis by complement

      INTERNATIONAL JOURNAL OF CANCER
    57. Hoffmann, P; Mueller, N; Shively, JE; Fleischer, B; Neumaier, M
      Fusion proteins of B7.1 and a carcinoembryonic antigen (CEA)-specific antibody fragment opsonize CEA-expressing tumor cells and coactivate T-cell immunity

      INTERNATIONAL JOURNAL OF CANCER
    58. van der Burg, SH; Ressing, ME; Kwappenberg, KMC; de Jong, A; Straathof, K; de Jong, J; Geluk, A; van Meugaarden, KE; Franken, KLMC; Ottenhoff, THM; Fleuren, GJ; Kenter, G; Melief, CJM; Offringa, R
      Natural T-HELPER immunity against human papillomavirus type 16 (HPV16) E7-derived peptide epitopes in patients with HPV16-positive cervical lesions: Identification of 3 human leukocyte antigen class II-restricted epitopes

      INTERNATIONAL JOURNAL OF CANCER
    59. Specht, C; Bexten, S; Kolsch, E; Pauels, HG
      Prostaglandins, but not tumor-derived IL-10, shut down concomitant tumor-specific CTL responses during murine plasmacytoma progression

      INTERNATIONAL JOURNAL OF CANCER
    60. Johnsen, AK; France, J; Nagy, N; Askew, D; Abdul-Karim, FW; Gerson, SL; Sy, MS; Harding, CV
      Systemic deficits in transporter for antigen presentation (TAP)-1 or proteasome subunit LMP2 have little or no effect on tumor incidence

      INTERNATIONAL JOURNAL OF CANCER
    61. Jung, G; Brandl, M; Eisner, W; Fraunberger, P; Reifenbeger, G; Schlegel, U; Wiestler, OD; Reulen, FJ; Wilmanns, W
      Local immunotherapy of glioma patients with a combination of 2 bispecific antibody fragments and resting autologous lymphocytes: Evidence for in situT-cell activation and therapeutic efficacy

      INTERNATIONAL JOURNAL OF CANCER
    62. Salih, HR; Starling, GC; Knauff, M; Llewellyn, MB; Davis, PM; Pitts, WJ; Aruffo, A; Kiener, PA
      Retinoic acid and vitamin E modulate expression and release of CD178 in carcinoma cells: Consequences for induction of apoptosis in CD95-sensitive cells

      EXPERIMENTAL CELL RESEARCH
    63. Smola-Hess, S; Schnitzler, R; Hadaschik, D; Smola, H; Mauch, C; Krieg, T; Pfister, H
      CD40L induces matrix-metalloproteinase-9 but not tissue inhibitor of metalloproteinases-1 in cervical carcinoma cells: Imbalance between NF-kappa B and STAT3 activation

      EXPERIMENTAL CELL RESEARCH
    64. Ayyoub, M; Migliaccio, M; Guillaume, P; Lienard, D; Cerottini, JC; Romero, P; Levy, F; Speiser, DE; Valmori, D
      Lack of tumor recognition by hTERT peptide 540-548-specific CD8(+) T cellsfrom melanoma patients reveals inefficient antigen processing.

      EUROPEAN JOURNAL OF IMMUNOLOGY
    65. Housseau, F; Moorthy, A; Langer, DA; Robbins, PF; Gonzales, MI; Topalian, SL
      N-linked carbohydrates in tyrosinase are required for its recognition by human MHC class II-restricted CD4(+) T cells

      EUROPEAN JOURNAL OF IMMUNOLOGY
    66. Casares, N; Lasarte, JJ; de Cerio, ALD; Sarobe, P; Ruiz, M; Melero, I; Prieto, J; Borras-Cuesta, F
      Immunization with a tumor-associated CTL epitope plus a tumor-related or unrelated Th1 helper peptide elicits protective CTL immunity

      EUROPEAN JOURNAL OF IMMUNOLOGY
    67. Chaux, P; Lethe, B; Van Snick, J; Corthals, J; Schultz, ES; Cambiaso, CL; Boon, T; van der Bruggen, P
      A MAGE-1 peptide recognized on HLA-DR15 by CD4(+) T cells

      EUROPEAN JOURNAL OF IMMUNOLOGY
    68. Tafuro, S; Meier, UC; Dunbar, PR; Jones, EY; Layton, GT; Hunter, MG; Bell, JI; McMichael, AJ
      Reconstitution of antigen presentation in HLA class I-negative cancer cells with peptide-beta 2m fusion molecules

      EUROPEAN JOURNAL OF IMMUNOLOGY
    69. Chiodoni, C; Stoppacciaro, A; Sangaletti, S; Gri, G; Cappetti, B; Koezuka, Y; Colombo, MP
      Different requirements for alpha-galactosylceramide and recombinant IL-12 antitumor activity in the treatment of C-26 colon carcinoma hepatic metastases

      EUROPEAN JOURNAL OF IMMUNOLOGY
    70. Guinn, BA; Bertram, EM; DeBenedette, MA; Berinstein, NL; Watts, TH
      4-1BBL enhances anti-tumor responses in the presence or absence of CD28 but CD28 is required for protective immunity against parental tumors

      CELLULAR IMMUNOLOGY
    71. Bergmann-Leitner, ES; Abrams, SI
      Positive and negative consequences of soluble Fas ligand produced by an antigen-specific CD4(+) T cell response in human carcinoma immune interactions

      CELLULAR IMMUNOLOGY
    72. Bishop, GA; Ramirez, LM; Baccam, M; Busch, LK; Pederson, LK; Tomai, MA
      The immune response modifier resiquimod mimics CD40-induced B cell activation

      CELLULAR IMMUNOLOGY
    73. Shimizu, M; Fontana, A; Takeda, Y; Yoshimoto, T; Tsubura, A; Matsuzawa, A
      Fas/Apo-1 (CD95)-mediated apoptosis of neutrophils with Fas ligand (CD95L)-expressing tumors is crucial for induction of inflammation by neutrophilicpolymorphonuclear leukocytes associated with antitumor immunity

      CELLULAR IMMUNOLOGY
    74. Strome, SE; Martin, B; Flies, D; Tamada, K; Chapoval, AI; Sargent, DJ; Shu, SY; Chen, LP
      Enhanced therapeutic potential of adoptive immunotherapy by in vitro CD28/4-1BB costimulation of tumor-reactive T cells against a poorly immunogenic,major histocompatibility complex class I-negative A9P melanoma

      JOURNAL OF IMMUNOTHERAPY
    75. Sabel, MS; Conway, TF; Chen, FA; Bankert, RB
      Monoclonal antibodies directed against the T-cell activation molecule CD137 (interleukin-A or 4-1BB) block human lymphocyte-mediated suppression of tumor xenografts in severe combined immunodeficient mice

      JOURNAL OF IMMUNOTHERAPY
    76. Merad, M; Angevin, E; Wolfers, T; Flament, C; Lorenzi, I; Triebel, F; Escudier, B; Zitvogel, L
      Generation of monocyte-derived dendritic cells from patients with renal cell cancer: Modulation of their functional properties after therapy with biological response modifiers (IFN-alpha plus IL-2 and IL-12)

      JOURNAL OF IMMUNOTHERAPY
    77. Ribas, A; Butterfield, LH; Hu, B; Dissette, VB; Chen, AY; Koh, A; Amarnani, SAN; Glaspy, JA; McBride, WH; Economou, JS
      Generation of T-cell immunity to a murine melanoma using MART-1-engineereddendritic cells

      JOURNAL OF IMMUNOTHERAPY
    78. Parker, G; Fernandes, H; Chong, SY; Czarneski, J; Ra, H; Lin, YC; Raveche, E
      Antisense IL-10 abrogates the inhibitory effects of IL-10 production by transfected tumor cells

      CYTOKINES CELLULAR & MOLECULAR THERAPY
    79. Kuriyama, Y; Kawanishi, Y; Otawa, M; Utsumi, K; Ohyashiki, K
      Circulating and tumor-infiltrating gamma delta T cells in patients with B-cell lymphomas

      LEUKEMIA & LYMPHOMA
    80. Kuriyama, S; Mitoro, A; Tsujinoue, H; Toyokawa, Y; Nakatani, T; Yoshiji, H; Tsujimoto, T; Okuda, H; Nagao, S; Fukui, H
      Electrochemotherapy can eradicate established colorectal carcinoma and leaves a systemic protective memory in mice

      INTERNATIONAL JOURNAL OF ONCOLOGY
    81. Song, W; Tong, Y; Carpenter, H; Kong, HL; Crystal, RG
      Persistent, antigen-specific, therapeutic antitumor immunity by dendritic cells genetically modified with an adenoviral vector to express a model tumor antigen

      GENE THERAPY
    82. Kim, YS; Sonn, CH; Paik, SG; Bothwell, ALM
      Tumor cells expressing membrane-bound form of IL-4 induce antitumor immunity

      GENE THERAPY
    83. Marton, I; Johnson, SE; Damjanov, I; Currier, KS; Sundberg, JP; Knowles, BB
      Expression and immune recognition of SV40 Tag in transgenic mice that develop metastatic osteosarcomas

      TRANSGENIC RESEARCH
    84. Yue, FY; Cao, L; Hemmi, S; Geertsen, R; Laine, E; Burg, G; Dummer, R
      Upregulation of interleukin-12 receptor on peripheral blood mononuclear cells and HLA class I, HLA class II or ICAM-1 on melanoma cells by B7.1 and interleukin-12: a mechanism for immunostimulatory impact of melanoma cells adenovirally transfected with B7.1 and IL12?

      MELANOMA RESEARCH
    85. Kurt, RA; Park, JA; Schluter, SF; Marchalonis, JJ; Akporiaye, ET
      TCR V-beta usage and clonality of T cells isolated from progressing and rejected tumor sites before and after in vitro culture

      INTERNATIONAL IMMUNOLOGY
    86. Levy, DE; Gilliland, DG
      Divergent roles of STAT1 and STAT5 in malignancy as revealed by gene disruptions in mice

      ONCOGENE
    87. Rakhmilevich, AL; Janssen, K; Hao, ZL; Sondel, PM; Yang, NS
      Interleukin-12 gene therapy of a weakly immunogenic mouse mammary carcinoma results in reduction of spontaneous lung metastases via a T-cell-independent mechanism

      CANCER GENE THERAPY
    88. Termeer, CC; Schirrmacher, V; Brocker, EB; Becker, JC
      Newcastle disease virus infection induces B7-1/B7-2-independent T-cell costimulatory activity in human melanoma cells

      CANCER GENE THERAPY
    89. Jones, RK; Pope, IM; Kinsella, AR; Watson, AJM; Christmas, SE
      Combined suicide and granulocyte-macrophage colony-stimulating factor genetherapy induces complete tumor regression and generates antitumor immunity

      CANCER GENE THERAPY
    90. Shibuya, TY; Wei, WZ; Zormeier, M; Ensley, J; Sakr, W; Mathog, RH; Meleca, RJ; Yoo, GH; June, CH; Levine, BL; Lum, LG
      Anti-CD3/anti-CD28 bead stimulation overcomes CD3 unresponsiveness in patients with head and neck squamous cell carcinoma

      ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY
    91. Weynants, P
      Immunity and lung cancer: perspectives for an antitumor vaccine

      REVUE DES MALADIES RESPIRATOIRES
    92. Nielsen, MB; Marincola, FM
      Melanoma vaccines: the paradox of T cell activation without clinical response

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    93. Cerundolo, V
      Use of major histocompatibility complex class I tetramers to monitor tumor-specific cytotoxic T lymphocyte response in melanoma patients

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    94. Moerch, U; Schrama, D; Guldberg, P; Seremet, T; Zeuthen, J; Becker, JC; Straten, PT
      Comparative delineation of T cell clonotypes in coexisting syngeneic B16 melanoma

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    95. Kim, BG; Joo, HG; Chung, IS; Chung, HY; Woo, HJ; Yun, YS
      Inhibition of interieukin-10 (IL-10) production from MOPC 315 tumor cells by IL-10 antisense oligodeoxynucleotides enhances cell-mediated immune responses

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    96. Rosales, C; Graham, VV; Rosas, GA; Merchant, H; Rosales, R
      A recombinant vaccinia virus containing the papilloma E2 protein promotes tumor regression by stimulating macrophage antibody-dependent cytotoxicity

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    97. Bergmann-Leitner, ES; Abrams, SI
      Influence of interferon gamma on modulation of Fas expression by human colon carcinoma cells and their subsequent sensitivity to antigen-specific CD8(+) cytotoxic T lymphocyte attack

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    98. Ichii, S; Imai, Y; Irimura, T
      Initial steps in lymph node metastasis formation in an experimental system: possible involvement of recognition by macrophage C-type lectins

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    99. Felzmann, T; Buchberger, M; Jechlinger, M; Kircheis, R; Wagner, E; Gadner, H
      Xenogenization by tetanus toroid loading into lymphoblastoid cell lines and primary human tumor cells mediated by polycations and liposomes

      CANCER LETTERS
    100. Apostolopoulos, V; Barnes, N; Pietersz, GA; McKenzie, IFC
      Ex vivo targeting of the macrophage mannose receptor generates anti-tumor CTL responses

      VACCINE


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 25/01/21 alle ore 00:08:59